http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09218203-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9fde776724301dc06bcd09c85a61d5ab
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4713
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
filingDate 1996-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2d25753804409368885e85bb40f760b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12f0d490d3fb2ae00999fbbc98eccb86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbedb571e7b89ab62ec528f254ae9585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_125e3139cf2299f354bc64356583e97c
publicationDate 1997-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H09218203-A
titleOfInvention Kamihara Sm-D peptide and its use, especially for diagnostic method of SLE
abstract (57) Abstract: (Corrected) SOLUTION: Consists of 35 to 45 amino acids, which are capable of forming a conformational epitope and binding to autoantibodies, as present in systemic lupus erythematosus (SLE). Peptide of the antigen Sm-D. Particularly preferred is VEPKVKSKKREAVA It is a peptide consisting of 37 amino acids having the structure GRGRGRGRGRGRGRGRGRGRGGGPRR, or mutants and variants thereof. [Effect] It is possible to perform highly reliable diagnosis of SLE. Moreover, it is extremely suitable not only for diagnosis of SLE but also for treatment control (monitoring) and production of a drug for SLE.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10875916-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008007600-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015505244-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10131709-B2
priorityDate 1995-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9502
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID402966
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID81781
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID744238
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20646
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48534
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC9X4J1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05431
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID780877
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395298
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ03023
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414865469
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6638

Total number of triples: 41.